NCT03725852 A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT03717012 Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE4
NCT03711435 Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics Status COMPLETED Phase N/A
NCT03711162 A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care Status TERMINATED Phase PHASE3
NCT03710824 Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib Status COMPLETED Phase N/A
NCT03692481 Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving Pirfenidone Status UNKNOWN Phase NA
NCT03591926 A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Status WITHDRAWN Phase PHASE2
NCT03588260 Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT03573505 An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT03567785 Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT03562416 Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects Status TERMINATED Phase PHASE2
NCT03562247 Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase NA
NCT03560154 Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease Status UNKNOWN Phase NA
NCT03548181 Feasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF) Status UNKNOWN Phase PHASE2
NCT03538301 JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF Status COMPLETED Phase PHASE2